Review: Immune-Related Adverse Events With Use of Checkpoint Inhibitors for Immunotherapy of Cancer
Arthritis and Rheumatology - United Kingdom
doi 10.1002/art.40043
Full Text
Open PDFAbstract
Available in full text
Date
March 3, 2017
Authors
Publisher
Wiley